Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Neos Therapeutics
company
About
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
- 101 - 250
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Life Science,Medical,Therapeutics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 101 - 250
- Operating Status
- Active
The Neos Therapeutics team is dedicated to creating high-quality products and partnering with pharmaceutical and consumer healthcare companies to address key medical needs.Neos Therapeutics’ research and development (R&D) and fully integrated state of the art, FDA approved manufacturing facility is located in the Dallas/Fort Worth area.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$35.50M
Neos Therapeutics has raised a total of
$35.50M
in funding over 2 rounds. Their latest funding was raised on
Apr 23, 2014 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 23, 2014 | Debt Financing | $20M | 1 | — | — | Detail |
| Mar 4, 2014 | Series C | $15.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Neos Therapeutics is funded by 2 investors.
Hercules Capital
and Crabtree Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Hercules Capital
|
— | Debt Financing |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
